One-year cumulative safety review of adverse effects reported after vaccination with Ervebo (rVSV-ZEBOV) in French volunteer professionals leaving for Ebola virus disease (EVD) epidemic areas in Democratic Republic of Congo (DRC)

Massy, N; Boulay, C; Andriamanantena, D; Ficko, C; Chartier, C

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021; 35 (): 55